Factors influencing atypical clinical presentations during the 2017 Madagascar pneumonic plague outbreak: a prospective cohort study
In late 2017, Madagascar experienced a large urban outbreak of pneumonic plague, the largest outbreak to date this century. During the outbreak, there were widespread reports of plague patients presenting with atypical symptoms, such as prolonged duration of illness and upper respiratory tract sympt...
Main Authors: | Salam, AP, Raberahona, M, Andriantsalama, P, Read, L, Andrianarintsiferantsoa, F, Razafinambinintsoa, T, Rakotomalala, R, Hasiniatsy, RNE, Razafimandimby, D, Castle, L, Funk, A, Mangahasimbola, RT, Renaud, B, Bertherat, E, Lovering, A, Heraud, J-M, Andrianaivoarimanana, V, Frédérique, R, Razanajatovo, N, Baril, L, Fontanet, A, Rajerison, M, Horby, P, Randria, M, Randremanana, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Tropical Medicine and Hygiene
2020
|
Similar Items
-
Clinical characteristics of patients admitted to pneumonic plague treatment centers during the 2017 madagascar pneumonic plague outbreak: A prospective observational study
by: Salam, A, et al.
Published: (2018) -
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
by: Randremanana, RV, et al.
Published: (2020) -
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol
by: Randremanana, RV, et al.
Published: (2024) -
Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report
by: Voahangy Andrianaivoarimanana, et al.
Published: (2018-05-01) -
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol
by: Rindra Vatosoa Randremanana, et al.
Published: (2024-07-01)